• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chest. The Occurrence and Impact of Bacterial Organisms Complicating Critical Care Illness Associated with Influenza A(H1N1) infection

Giuseppe

Emeritus
[Source: Chest, full page: (LINK). Abstract, edited.]

Original Research| February 7, 2013

The Occurrence and Impact of Bacterial Organisms Complicating Critical Care Illness Associated with Influenza A(H1N1) infection


John Muscedere, MD, FRCPC; Marianna Ofner, PhD; Anand Kumar, MD, FRCPC; Jennifer Long, MSc; Francois Lamontagne, MD, FRCPC; Deborah Cook, MD, MSc, FRCPC; Allison McGeer, MD, MSc, FRCPC; Clarence Chant, PharmD; John Marshall, MD, FRCPC; Philippe Jouvet, MD, PhD; Robert Fowler, MD, MS, FRCPC; for the ICU-FLU Group and the Canadian Critical Care Trials Group

Author and Funding Information: Department of Medicine, Queen?s University, Kingston, muscedej@kgh.kari.net (Muscedere); Public Health Agency of Canada, marianna.ofner@hc-sc.gc.ca (Ofner); Winnipeg Health Sciences Centre and St. Boniface Hospital, University of Manitoba, akumar61@yahoo.com (Kumar); Sunnybrook Health Sciences Center, University of Toronto, jenalon@gmail.com (Long); Clinical Research Centre ?tienne Le Bel and Department of Medicine, Universit? de Sherbrooke, francoislamontagne@me.com (Lamontagne); Faculty of Health Sciences, McMaster University, debcook@mcmaster.ca (Cook); Mt. Sinai Hospital, University of Toronto, amcgeer@mtsinai.on.ca (McGeer); St. Michael?s Hospital, ChantC@smh.ca (Chant); St. Michael?s Hospital, MarshallJ@smh.ca (Marshall); Sainte-Justine Research Center, Universit? de Montr?al, philippe.jouvet@umontreal.ca (Jouvet); Sunnybrook Health Sciences Center, University of Toronto, Rob.Fowler@sunnybrook.ca (Fowler)

Corresponding Author: Dr. John Muscedere, Room 5-411, Angada 4, Kingston General Hospital, 76 Stuart Street, Kingston, Ontario, K7M 9H3 Email: muscedej@kgh.kari.net

CHEST. February 7, 2013doi:10.1378/chest.12-1861 - Published online



Abstract

Purpose:

Although secondary infections are recognized as a cause of morbidity and mortality in seasonal influenza, their frequency, characteristics and associated clinical outcomes in Influenza A (H1N1)-related critical illness are unknown.


Methods:

In a prospective cohort of adult patients admitted to Canadian Intensive Care Units (ICUs) with H1N1 infection, the frequency and associated clinical outcomes of prevalent (culture taken within 72 hours of ICU admission) and ICU-acquired (culture taken after 72 hours from ICU admission) positive bacterial cultures were determined.


Results:

Among 681 patients the mean age was 47.9 years (standard deviation [SD] 15.1), APACHE II was 21.0 (9.9) and 573 (84.0%) were invasively mechanical ventilated (MV). Positive cultures were obtained in 259 (38.0 %): 77 (29.7%) prevalent; 115 (44.4%) ICU-acquired; 40 (15.4%) had both; culture date was unavailable in 27 (10.4%). The most common bacterial organisms isolated were coagulase negative staphylococci, Staphylococcus aureus, Pseudomonas sp. and Streptococcus pneumoniae. Antibiotics were prescribed in 661 (97.1%) with 3.8 (1.9) prescriptions per patient. Patients with any positive culture had longer days of MV [mean(SD); 15.2 (10.7) vs. 10.7 (9.0), p< 0.0001], ICU stay [median(IQR);18.2 (12.5) vs. 10.8 (9.0) days, p< 0.0001], hospitalization [median(IQR); 30.7 (20.7) vs. 19.2 (17.4) days, p< 0.0001] and a trend towards increased hospital mortality (25.1% vs. 19.9%, p = 0.15). Patients with ICU-acquired positive cultures had worse outcomes compared to those with positive prevalent cultures or who were culture negative.


Conclusion:

Culture-based evidence of secondary infections commonly complicates Influenza A(H1N1)-related critical illness and is associated with worse clinical outcomes despite nearly ubiquitous antibiotic administration.
-
------
 
Back
Top Bottom